These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25066364)

  • 1. Highly stable, fluorescence-labeled heptapeptides substituted with a D-amino acid for the specific detection of oxidized low-density lipoprotein in plasma.
    Sato A; Yamanaka H; Oe K; Yokoyama I; Yamazaki Y; Ebina K
    Chem Biol Drug Des; 2015 Mar; 85(3):348-55. PubMed ID: 25066364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel fluorescently labeled peptide compounds for detection of oxidized low-density lipoprotein at high specificity.
    Sato A; Yamanaka H; Oe K; Yamazaki Y; Ebina K
    Chem Biol Drug Des; 2014 Oct; 84(4):443-9. PubMed ID: 24717143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of Novel Diagnostic Agents for Atherosclerosis Using Fluorescence-labeled Peptides].
    Sato A
    Yakugaku Zasshi; 2016; 136(10):1367-1372. PubMed ID: 27725385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescently labeled undecapeptide derived from a protein in royal jelly of the honeybee-royalisin-for specific detection of oxidized low-density lipoprotein.
    Sato A; Unuma H; Yamazaki Y; Ebina K
    J Pept Sci; 2018 Jun; 24(4-5):e3072. PubMed ID: 29602217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fluorescence-Labeled Heptapeptide, (FITC)KP6, as an Efficient Probe for the Specific Detection of Oxidized and Minimally Modified Low-Density Lipoprotein.
    Sato A; Ueda C; Kimura R; Kobayashi C; Yamazaki Y; Ebina K
    J Fluoresc; 2016 May; 26(3):1141-50. PubMed ID: 27063871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Method for In Vitro Measurement of Oxidized Low-Density Lipoprotein in Blood, Using Its Antibody, Fluorescence-Labeled Heptapeptide and Polyethylene Glycol.
    Sato A; Yamazaki Y; Ebina K
    J Fluoresc; 2017 Nov; 27(6):1985-1993. PubMed ID: 28687985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors.
    Sato A; Yokoyama I; Ebina K
    Eur J Pharmacol; 2015 Oct; 764():202-207. PubMed ID: 26142829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human estrogen sulfotransferase and its related fluorescently labeled decapeptides specifically interact with oxidized low-density lipoprotein.
    Sato A; Yamazaki M; Watanabe H; Sakurai E; Ebina K
    J Pept Sci; 2020 Oct; 26(10):e3274. PubMed ID: 32633098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of IL-6 and TNF in Foam Cell Formation: An Improved Method Using Fluorescein Isothiocyanate (FITC) Probe.
    Castro CA; Buzinari TC; Lino RLB; Araújo HSS; Aníbal FF; Verzola RMM; Bagnato VS; Inada NM; Rodrigues GJ
    Arq Bras Cardiol; 2022 Oct; 119(4):533-541. PubMed ID: 35946754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction.
    Kayo S; Ohsawa M; Ehara S; Naruko T; Ikura Y; Hai E; Yoshimi N; Shirai N; Tsukamoto Y; Itabe H; Higuchi K; Arakawa T; Ueda M
    Am Heart J; 2004 Nov; 148(5):818-25. PubMed ID: 15523312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II induces the aggregation of native and oxidized low-density lipoprotein.
    Sato A; Ueda C; Kimura R; Kobayashi C; Yamazaki Y; Ebina K
    Eur Biophys J; 2018 Jan; 47(1):1-9. PubMed ID: 28401261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of lecithin-like oxidized low-density lipoprotein receptor-1 on p38 mitogen-activated protein kinase induced by oxidized low-density lipoprotein in endothelial cells].
    Hao WJ; Bai XJ; Yang XH
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1697-700. PubMed ID: 16854325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
    Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
    Yang SH; Li YT; Du DY
    Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.
    Nakajima K; Nakano T; Tanaka A
    Clin Chim Acta; 2006 May; 367(1-2):36-47. PubMed ID: 16448638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic biotinylated peptide, BP21, inhibits the induction of mRNA expression of inflammatory substances by oxidized- and lyso-phosphatidylcholine.
    Sato A; Kumagai T; Ebina K
    Drug Dev Res; 2014 Jun; 75(4):246-56. PubMed ID: 24890951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of plasma low-density lipoprotein and oxidized low-density lipoprotein levels with coronary lesion severities in patients with coronary artery disease].
    He XM; Xiang DC; He JX; Hong CJ; Qiu J; Ma J; Zhang JX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 May; 35(5):451-6. PubMed ID: 17711689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel oxidized low-density lipoprotein-binding protein, Asp-hemolysin, recognizes lysophosphatidylcholine.
    Kudo Y; Ootani T; Kumagai T; Fukuchi Y; Ebin K; Yokota K
    Biol Pharm Bull; 2002 Jun; 25(6):787-90. PubMed ID: 12081148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic peptides neutralize Ox-LDL, prevent its uptake by macrophages, and attenuate inflammatory response.
    Aluganti Narasimhulu C; Selvarajan K; Brown M; Parthasarathy S
    Atherosclerosis; 2014 Sep; 236(1):133-41. PubMed ID: 25036240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation.
    Sakamoto Y; Miyazaki A; Tamagawa H; Wang GP; Horiuchi S
    Atherosclerosis; 2005 Nov; 183(1):85-93. PubMed ID: 15907858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.